Nu Skin Enterprises (NUS) Competitors $9.26 -0.07 (-0.75%) Closing price 07/11/2025 03:59 PM EasternExtended Trading$9.23 -0.03 (-0.32%) As of 07/11/2025 04:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NUS vs. COTY, HLF, USNA, NATR, MED, VERU, EL, IPAR, PBH, and HELEShould you be buying Nu Skin Enterprises stock or one of its competitors? The main competitors of Nu Skin Enterprises include Coty (COTY), Herbalife (HLF), USANA Health Sciences (USNA), Nature's Sunshine Products (NATR), MEDIFAST (MED), Veru (VERU), Estee Lauder Companies (EL), Interparfums (IPAR), Prestige Consumer Healthcare (PBH), and Helen of Troy (HELE). Nu Skin Enterprises vs. Its Competitors Coty Herbalife USANA Health Sciences Nature's Sunshine Products MEDIFAST Veru Estee Lauder Companies Interparfums Prestige Consumer Healthcare Helen of Troy Coty (NYSE:COTY) and Nu Skin Enterprises (NYSE:NUS) are both consumer staples companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and media sentiment. Is COTY or NUS more profitable? Nu Skin Enterprises has a net margin of -2.30% compared to Coty's net margin of -6.60%. Nu Skin Enterprises' return on equity of 6.99% beat Coty's return on equity.Company Net Margins Return on Equity Return on Assets Coty-6.60% 5.61% 1.87% Nu Skin Enterprises -2.30%6.99%3.25% Do analysts prefer COTY or NUS? Coty currently has a consensus target price of $7.80, suggesting a potential upside of 53.79%. Nu Skin Enterprises has a consensus target price of $6.88, suggesting a potential downside of 25.76%. Given Coty's stronger consensus rating and higher possible upside, equities analysts plainly believe Coty is more favorable than Nu Skin Enterprises.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Coty 2 Sell rating(s) 8 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.37Nu Skin Enterprises 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do institutionals and insiders hold more shares of COTY or NUS? 42.4% of Coty shares are owned by institutional investors. Comparatively, 82.8% of Nu Skin Enterprises shares are owned by institutional investors. 6.0% of Coty shares are owned by insiders. Comparatively, 2.0% of Nu Skin Enterprises shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has more risk & volatility, COTY or NUS? Coty has a beta of 1.91, suggesting that its share price is 91% more volatile than the S&P 500. Comparatively, Nu Skin Enterprises has a beta of 0.95, suggesting that its share price is 5% less volatile than the S&P 500. Does the media refer more to COTY or NUS? In the previous week, Coty had 3 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 5 mentions for Coty and 2 mentions for Nu Skin Enterprises. Coty's average media sentiment score of 0.57 beat Nu Skin Enterprises' score of 0.37 indicating that Coty is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Coty 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nu Skin Enterprises 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable valuation & earnings, COTY or NUS? Coty has higher revenue and earnings than Nu Skin Enterprises. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than Coty, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCoty$6.12B0.72$89.40M-$0.48-10.56Nu Skin Enterprises$1.73B0.26-$146.59M-$0.80-11.58 SummaryCoty beats Nu Skin Enterprises on 12 of the 16 factors compared between the two stocks. Get Nu Skin Enterprises News Delivered to You Automatically Sign up to receive the latest news and ratings for NUS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NUS vs. The Competition Export to ExcelMetricNu Skin EnterprisesCOSMETICS&TLTRS IndustryStaples SectorNYSE ExchangeMarket Cap$457.07M$3.43B$16.22B$20.65BDividend Yield2.59%2.25%3.11%3.72%P/E Ratio-11.5727.6319.7827.84Price / Sales0.2621.2246.0842.37Price / Cash4.1217.5614.7022.32Price / Book0.713.806.094.57Net Income-$146.59M$37.65M$680.31M$989.30M7 Day Performance3.81%-3.43%2.12%0.20%1 Month Performance22.16%10.68%3.60%5.53%1 Year Performance-10.96%-16.54%4.27%10.30% Nu Skin Enterprises Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NUSNu Skin Enterprises2.994 of 5 stars$9.26-0.8%$6.88-25.8%-11.0%$457.07M$1.73B-11.573,100COTYCoty4.3651 of 5 stars$4.97-2.4%$7.80+56.9%-51.4%$4.44B$6.12B21.2111,791HLFHerbalife4.2701 of 5 stars$9.65-3.3%$11.50+19.2%-5.9%$1.02B$4.99B4.848,600USNAUSANA Health Sciences3.8532 of 5 stars$32.14-1.9%$36.00+12.0%-27.2%$610.28M$854.50M17.661,700NATRNature's Sunshine Products1.7164 of 5 stars$16.02+2.8%$18.33+14.4%+4.0%$287.84M$454.36M26.42850Positive NewsHigh Trading VolumeMEDMEDIFAST3.4736 of 5 stars$14.62+0.3%$16.50+12.9%-23.2%$160.25M$602.46M11.57870VERUVeru2.8925 of 5 stars$0.58-3.8%$4.00+585.4%-36.6%$88.92M$16.89M0.00230Positive NewsGap UpELEstee Lauder Companies4.1161 of 5 stars$85.82-3.3%$74.45-13.2%-11.8%$31.92B$15.61B43.2862,000Positive NewsAnalyst ForecastIPARInterparfums3.9145 of 5 stars$136.05-1.8%$157.60+15.8%+4.8%$4.45B$1.45B26.59530Positive NewsPBHPrestige Consumer Healthcare3.8375 of 5 stars$78.93-1.3%$93.33+18.2%+8.5%$3.95B$1.14B17.66540Positive NewsHELEHelen of Troy1.9314 of 5 stars$30.10-7.8%$54.33+80.5%-64.8%$749.31M$1.91B5.171,883Trending NewsEarnings ReportAnalyst Forecast Related Companies and Tools Related Companies Coty Competitors Herbalife Competitors USANA Health Sciences Competitors Nature's Sunshine Products Competitors MEDIFAST Competitors Veru Competitors Estee Lauder Companies Competitors Interparfums Competitors Prestige Consumer Healthcare Competitors Helen of Troy Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NUS) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nu Skin Enterprises, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nu Skin Enterprises With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
